The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Fibronectin regulates calvarial osteoblast differentiation
Abstract
The secretion of fibronectin by differentiating osteoblasts and its accumulation at sites of osteogenesis suggest that fibronectin participates in bone formation. To test this directly, we determined whether fibronectin-cell interactions regulate progressive differentiation of cultured fetal rat calvarial osteoblasts. Spatial distributions of α5 integrin subunit, fibronectin, osteopontin (bone sialoprotein I) and osteocalcin (bone Gla-protein) were similar in fetal rat calvaria and mineralized, bone-like nodules formed by cultured osteoblasts. Addition of anti-fibronectin antibodies to cultures at confluence reduced subsequent formation of nodules to less than 10% of control values, showing that fibronectin is required for normal nodule morphogenesis. Anti-fibronectin antibodies selectively inhibited steady-state expression of mRNA for genes associated with osteoblast differentiation; mRNA levels for alkaline phosphatase and osteocalcin were suppressed, whereas fibronectin, type I collagen and osteopontin were unaffected. To identify functionally relevant domains of fibronectin, we treated cells with soluble fibronectin fragments and peptides. Cell-binding fibronectin fragments (type III repeats 6-10) containing the Arg-Gly-Asp (RGD) sequence blocked both nodule initiation and maturation, whether or not they contained a functional synergy site. In contrast, addition of the RGD-containing peptide GRGDSPK alone did not inhibit nodule initiation, although it did block nodule maturation. Thus, in addition to the RGD sequence, other features of the large cell-binding fragments contribute to the full osteogenic effects of fibronectin. Nodule formation and osteoblast differentiation resumed after anti-fibronectin antibodies or GRGDSPK peptides were omitted from the media, showing that the inhibition was reversible and the treatments were not cytotoxic. Outside the central cell-binding domain, peptides from the IIICS region and antibodies to the N terminus did not inhibit nodule formation. We conclude that osteoblasts interact with the central cell-binding domain of endogenously produced fibronectin during early stages of differentiation, and that these interactions regulate both normal morphogenesis and gene expression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrins: Versatility, modulation, and signaling in cell adhesion
Hynes, R. O. (1992) · Cell · doi:10.1016/0092-8674(92)90115-s · Cited by 9,859
Signal transduction from the extracellular matrix.
Juliano, R. L., & Haskill, S. (1993) · The Journal of cell biology · doi:10.1083/jcb.120.3.577 · Cited by 1,683
Regulation of development and differentiation by the extracellular matrix
Adams, J. C., & Watt, F. M. (1993) · Development · doi:10.1242/dev.117.4.1183 · Cited by 1,208
Werb, Z., Tremble, P. M., Behrendtsen, O., Crowley, E., & Damsky, C. H. (1989) · The Journal of cell biology · doi:10.1083/jcb.109.2.877 · Cited by 1,059
Self-citationStein, G. S., Lian, J. B., & Owen, T. A. (1990) · The FASEB Journal · doi:10.1096/fasebj.4.13.2210157 · Cited by 935
Mineralized bone nodules formedin vitro from enzymatically released rat calvaria cell populations
Bellows, C. G., Aubin, J. E., Heersche, J. N. M., & Antosz, M. E. (1986) · Calcified Tissue International · doi:10.1007/bf02556874 · Cited by 846
Toward a molecular understanding of skeletal development
Erlebacher, A., Filvaroff, E. H., Gitelman, S. E., & Derynck, R. (1995) · Cell · doi:10.1016/0092-8674(95)90487-5 · Cited by 685
Streuli, C. H., Bailey, N., & Bissell, M. J. (1991) · The Journal of cell biology · doi:10.1083/jcb.115.5.1383 · Cited by 676
Aota, S., Nomizu, M., & Yamada, K. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31456-4 · Cited by 633
Self-citationGenovese, C., Rowe, D., & Kream, B. (1984) · Biochemistry · doi:10.1021/bi00320a049 · Cited by 562
Cited by
LDL Receptor-Related Protein 5 (LRP5) Affects Bone Accrual and Eye Development
Gong, Y., Slee, R. B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A. M., Wang, H., Cundy, T., Glorieux, F. H., Lev, D., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00571-2 · Cited by 2,235
High Bone Density Due to a Mutation in LDL-Receptor–Related Protein 5
Boyden, L. M., Mao, J., Belsky, J., Mitzner, L., Farhi, A., Mitnick, M. A., Wu, D., Insogna, K., & Lifton, R. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013444 · Cited by 1,591
Keselowsky, B. G., Collard, D. M., & Garcı́a, A. J. (2004) · Biomaterials · doi:10.1016/j.biomaterials.2004.01.062 · Cited by 627
Regulation of Osteoblast Formation and Function
Aubin, J. E. (2001) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/a:1010011209064 · Cited by 465
Transglutaminase Regulation of Cell Function
Eckert, R. L., Kaartinen, M. T., Nurminskaya, M., Belkin, A. M., Colak, G., Johnson, G. V. W., & Mehta, K. (2014) · Physiological Reviews · doi:10.1152/physrev.00019.2013 · Cited by 419
Salasznyk, R. M., Williams, W. A., Boskey, A., Batorsky, A., & Plopper, G. E. (2004) · BioMed Research International · doi:10.1155/s1110724304306017 · Cited by 417
Mizuno, M., Fujisawa, R., & Kuboki, Y. (2000) · Journal of Cellular Physiology · doi:10.1002/1097-4652(200008)184:2<207::aid-jcp8>3.0.co;2-u · Cited by 384
Lai, C.-F., Chaudhary, L., Fausto, A., Halstead, L. R., Ory, D. S., Avioli, L. V., & Cheng, S.-L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m010021200 · Cited by 381
Moursi, A. M., Globus, R. K., & Damsky, C. H. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.18.2187 · Cited by 380
Self-citationXiao, G., Wang, D., Benson, M. D., Karsenty, G., & Franceschi, R. T. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.49.32988 · Cited by 374
Tambasco de Oliveira, P., & Nanci, A. (2004) · Biomaterials · doi:10.1016/s0142-9612(03)00539-8 · Cited by 360
Bone sialoprotein expression enhances osteoblast differentiation and matrix mineralization in vitro
Gordon, J. A. R., Tye, C. E., Sampaio, A. V., Underhill, T. M., Hunter, G. K., & Goldberg, H. A. (2007) · Bone · doi:10.1016/j.bone.2007.04.191 · Cited by 345
RGD-coated titanium implants stimulate increased bone formation in vivo
Ferris, D. (1999) · Biomaterials · doi:10.1016/s0142-9612(99)00161-1 · Cited by 286
Bio-adhesive Surfaces to Promote Osteoblast Differentiation and Bone Formation
García, A. J., & Reyes, C. D. (2005) · Journal of Dental Research · doi:10.1177/154405910508400502 · Cited by 281
Franceschi, R. T. (1999) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411990100010201 · Cited by 274
Fibronectin is a survival factor for differentiated osteoblasts
Globus, R. K., Doty, S. B., Lull, J. C., Holmuhamedov, E., Humphries, M. J., & Damsky, C. H. (1998) · Journal of Cell Science · doi:10.1242/jcs.111.10.1385 · Cited by 260
Self-citationThe use of platelet-rich plasma in bone reconstruction therapy
Intini, G. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.05.055 · Cited by 255
Extracellular matrix–integrin interactions in osteoblast function and tissue remodeling
Damsky, C. H. (1999) · Bone · doi:10.1016/s8756-3282(99)00106-4 · Cited by 187
Self-citationImpaired Bone Formation in Transgenic Mice Resulting from Altered Integrin Function in Osteoblasts
Zimmerman, D., Jin, F., Leboy, P., Hardy, S., & Damsky, C. (2000) · Developmental Biology · doi:10.1006/dbio.2000.9633 · Cited by 141
Self-citationCurrent understanding of osteoporosis associated with liver disease
Nakchbandi, I. A., & van der Merwe, S. W. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.166 · Cited by 98
Kirmizidis, G., & Birch, M. A. (2009) · Tissue Engineering Part A · doi:10.1089/ten.tea.2008.0137 · Cited by 49
Metadata
- Authors
- Moursi, A. M., Damsky, C. H., Lull, J., Zimmerman, D., Doty, S. B., Aota, S.-I., & Globus, R. K.
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 1996-06-01
- Volume
- 109
- Issue
- 6
- Pages
- 1369-1380
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W2129611079
- Cited by
- 301
- References
- 42
- FWCI
- 6.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.